Fast-Tracked to the Medicine Cabinet — President Trump's Executive Order Accelerates Psychedelic Therapies

On April 18, 2026, President Trump signed an Executive Order titled "Accelerating Medical Treatments for Serious Mental Illness," directing multiple federal agencies to accelerate research into, and access to, psychedelic drugs for the treatment of serious mental health conditions. The Executive Order represents a significant policy shift and carries meaningful implications for manufacturers of psychedelic therapies, companies operating in the broader innovative therapeutics space, and... By: Orrick, Herrington & Sutcliffe LLP